Young Su Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young Su Lim has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chul Geun Kim
Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul 04763, Korea
1 shared publication - Ho Chul Kang
Department of Physiology Ajou University School of Medicine Suwon Republic of Korea
1 shared publication - Hyeon Cheol Jin
Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul 04763, Korea
1 shared publication Jae Kyu Yi
Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul 04763, Korea
1 shared publicationJi Hyung Chae
Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul 04763, Korea
1 shared publication- June Ho Shin
Department of Otolaryngology–Head & Neck Surgery, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication
Latest Publications
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eadd4969
SUMOylation-mediated PSME3-20 S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
Transcription factor CP2c (also known as TFCP2, α-CP2, LSF, and LBP-1c) is involved in diverse ubiquitous and tissue/stage-specific cellular processes and in human malignancies such as cancer. Despite its importance, many fundamental regulatory mechanisms of CP2c are still unclear. Here, we uncover an unprecedented mechanism of CP2c degradation via a previously unidentified SUMO1/PSME3/20 S proteasome pathway and its biological meaning. CP2c is SUMOylated in a SUMO1-dependent way, and SUMOylated CP2c is degraded through the ubiquitin-independent PSME3 (also known as REGγ or PA28)/20 S proteasome system. SUMOylated PSME3 could also interact with CP2c to degrade CP2c via the 20 S proteasomal pathway. Moreover, precisely timed degradation of CP2c via the SUMO1/PSME3/20 S proteasome axis is required for accurate progression of the cell cycle. Therefore, we reveal a unique SUMO1-mediated uncanonical 20 S proteasome degradation mechanism via the SUMO1/PSME3 axis involving mutual SUMO-SIM interaction of CP2c and PSME3, providing previously unidentified mechanistic insights into the roles of dynamic degradation of CP2c in cell cycle progression.
- 27 January 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (4) , eadd4969
SUMOylation-mediated PSME3-20 S proteasomal degradation of transcription factor CP2c is crucial for cell cycle progression
Transcription factor CP2c (also known as TFCP2, α-CP2, LSF, and LBP-1c) is involved in diverse ubiquitous and tissue/stage-specific cellular processes and in human malignancies such as cancer. Despite its importance, many fundamental regulatory mechanisms of CP2c are still unclear. Here, we uncover an unprecedented mechanism of CP2c degradation via a previously unidentified SUMO1/PSME3/20 S proteasome pathway and its biological meaning. CP2c is SUMOylated in a SUMO1-dependent way, and SUMOylated CP2c is degraded through the ubiquitin-independent PSME3 (also known as REGγ or PA28)/20 S proteasome system. SUMOylated PSME3 could also interact with CP2c to degrade CP2c via the 20 S proteasomal pathway. Moreover, precisely timed degradation of CP2c via the SUMO1/PSME3/20 S proteasome axis is required for accurate progression of the cell cycle. Therefore, we reveal a unique SUMO1-mediated uncanonical 20 S proteasome degradation mechanism via the SUMO1/PSME3 axis involving mutual SUMO-SIM interaction of CP2c and PSME3, providing previously unidentified mechanistic insights into the roles of dynamic degradation of CP2c in cell cycle progression.